Daniel Nadler — SPARQNOW

At-a-Glance

Founder of OpenEvidence, an artificial intelligence company valued at $6 billion by Sequoia and Google Ventures, used by over a quarter of U.S. doctors.
Founded Kensho Technologies, an AI company acquired by S&P Global for $550 million in 2018.
Named to the TIME100 Health list in 2025 for his influence in global health.
Author of the poetry collection 'Lacunae' (2016), named by NPR as one of the Best Books of the Year.
Received a Ph.D. from Harvard University, with a doctoral thesis on credit derivatives.
Serves on the Digital Art Committee of the Whitney Museum and the Board of Directors of MoMA PS1.

Biography

Daniel Nadler is a Canadian-born entrepreneur and poet. He is the founder of OpenEvidence, an artificial intelligence company whose medical search engine is used by doctors for clinical decision support. OpenEvidence is backed by Sequoia and Google Ventures, and in October 2025, it announced a US$200 million Series C round, valuing it at US$6 billion. In 2025, Nadler was named to the TIME100 Health list of the 100 Most Influential People in global health.